7W3.F ACOTEC SCIEN.H. DL-00001

Healthcare Medical Devices Frankfurt Exchange
0.5500 EUR
Close of Nov 11, 2026
0.5400 1.59
Market cap
EUR 172M
P/E
-
P/B
0.93x
ROE
8.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 7W3.F undervalued?

Graham number

The Graham number of ACOTEC SCIEN.H. DL-00001 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ACOTEC SCIEN.H. DL-00001 fundamental analysis

No fundamental analysis for ACOTEC SCIEN.H. DL-00001 yet.

ACOTEC SCIEN.H. DL-00001 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ACOTEC SCIEN.H. DL-00001

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with a vascular interventional approach; and AcoArt Tulip & Litos, a paclitaxel coat…

Full company profile